411 related articles for article (PubMed ID: 16541136)
1. Marek's disease virus: from miasma to model.
Osterrieder N; Kamil JP; Schumacher D; Tischer BK; Trapp S
Nat Rev Microbiol; 2006 Apr; 4(4):283-94. PubMed ID: 16541136
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
[TBL] [Abstract][Full Text] [Related]
3. Use of Marek's disease vaccines: could they be driving the virus to increasing virulence?
Davison F; Nair V
Expert Rev Vaccines; 2005 Feb; 4(1):77-88. PubMed ID: 15757475
[TBL] [Abstract][Full Text] [Related]
4. Successful control of Marek's disease by vaccination.
Nair V
Dev Biol (Basel); 2004; 119():147-54. PubMed ID: 15742626
[TBL] [Abstract][Full Text] [Related]
5. Expression profiles of microRNAs encoded by the oncogenic Marek's disease virus reveal two distinct expression patterns in vivo during different phases of disease.
Luo J; Sun AJ; Teng M; Zhou H; Cui ZZ; Qu LH; Zhang GP
J Gen Virol; 2011 Mar; 92(Pt 3):608-20. PubMed ID: 21148277
[TBL] [Abstract][Full Text] [Related]
6. Construction of an infectious Marek's disease virus bacterial artificial chromosome and characterization of protection induced in chickens.
Cui HY; Wang YF; Shi XM; An TQ; Tong GZ; Lan DS; He L; Liu CJ; Wang M
J Virol Methods; 2009 Mar; 156(1-2):66-72. PubMed ID: 19026690
[TBL] [Abstract][Full Text] [Related]
7. Expression of chicken interleukin-2 by turkey herpesvirus increases the immune response against Marek's disease virus but fails to increase protection against virulent challenge.
Tarpey I; Davis PJ; Sondermeijer P; van Geffen C; Verstegen I; Schijns VE; Kolodsick J; Sundick R
Avian Pathol; 2007 Feb; 36(1):69-74. PubMed ID: 17364512
[TBL] [Abstract][Full Text] [Related]
8. A full UL13 open reading frame in Marek's disease virus (MDV) is dispensable for tumor formation and feather follicle tropism and cannot restore horizontal virus transmission of rRB-1B in vivo.
Blondeau C; Chbab N; Beaumont C; Courvoisier K; Osterrieder N; Vautherot JF; Denesvre C
Vet Res; 2007; 38(3):419-33. PubMed ID: 17506972
[TBL] [Abstract][Full Text] [Related]
9. Marek's disease: a model for protection against herpesvirus-induced tumours.
Schat KA
Cancer Surv; 1987; 6(1):1-37. PubMed ID: 2825984
[TBL] [Abstract][Full Text] [Related]
10. Marek's disease virus-encoded microRNAs: genomics, expression and function.
Luo J; Teng M; Fan J; Wang F; Zhou L; Deng R; Zhang G
Sci China Life Sci; 2010 Oct; 53(10):1174-80. PubMed ID: 20953939
[TBL] [Abstract][Full Text] [Related]
11. Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function.
Reddy SM; Lupiani B; Gimeno IM; Silva RF; Lee LF; Witter RL
Proc Natl Acad Sci U S A; 2002 May; 99(10):7054-9. PubMed ID: 11997455
[TBL] [Abstract][Full Text] [Related]
12. Marek's disease virus reactivation from latency: changes in gene expression at the origin of replication.
Parcells MS; Arumugaswami V; Prigge JT; Pandya K; Dienglewicz RL
Poult Sci; 2003 Jun; 82(6):893-8. PubMed ID: 12817443
[TBL] [Abstract][Full Text] [Related]
13. Marek's disease virus: lytic replication, oncogenesis and control.
Jarosinski KW; Tischer BK; Trapp S; Osterrieder N
Expert Rev Vaccines; 2006 Dec; 5(6):761-72. PubMed ID: 17184215
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome and proteome profiling of host responses to Marek's disease virus in chickens.
Haq K; Brisbin JT; Thanthrige-Don N; Heidari M; Sharif S
Vet Immunol Immunopathol; 2010 Dec; 138(4):292-302. PubMed ID: 21067815
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Marek's disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV.
Lee LF; Lupiani B; Silva RF; Kung HJ; Reddy SM
Vaccine; 2008 Mar; 26(15):1887-92. PubMed ID: 18313812
[TBL] [Abstract][Full Text] [Related]
16. Virus and host genomic, molecular, and cellular interactions during Marek's disease pathogenesis and oncogenesis.
McPherson MC; Delany ME
Poult Sci; 2016 Feb; 95(2):412-29. PubMed ID: 26755654
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization and phylogenetic analysis of a virulent Marek's disease virus field strain in broiler chickens in Japan.
Abd-Ellatieff HA; Abou Rawash AA; Ellakany HF; Goda WM; Suzuki T; Yanai T
Avian Pathol; 2018 Feb; 47(1):47-57. PubMed ID: 28762757
[TBL] [Abstract][Full Text] [Related]
18. Virulent Marek's disease virus generated from infectious bacterial artificial chromosome clones with complete DNA sequence and the implication of viral genetic homogeneity in pathogenesis.
Niikura M; Kim T; Silva RF; Dodgson J; Cheng HH
J Gen Virol; 2011 Mar; 92(Pt 3):598-607. PubMed ID: 21123546
[TBL] [Abstract][Full Text] [Related]
19. Induction of DNA Damages upon Marek's Disease Virus Infection: Implication in Viral Replication and Pathogenesis.
Bencherit D; Remy S; Le Vern Y; Vychodil T; Bertzbach LD; Kaufer BB; Denesvre C; Trapp-Fragnet L
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978699
[TBL] [Abstract][Full Text] [Related]
20. Construction and characterization of Marek's disease viruses having green fluorescent protein expression tied directly or indirectly to phosphoprotein 38 expression.
Prigge JT; Majerciak V; Hunt HD; Dienglewicz RL; Parcells MS
Avian Dis; 2004 Sep; 48(3):471-87. PubMed ID: 15529969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
